Single Dose Intravesical Apaziquone Postoperative in Patients Undergoing TURBT for Noninvasive Bladder Cancer (SPI-612)

NCT00598806 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

812

Enrollment

INDUSTRY

Sponsor class

Conditions

Bladder Cancer

Interventions

DRUG: Apaziquone
DRUG: Placebo
PROCEDURE: TURBT

Sponsor

Spectrum Pharmaceuticals, Inc